Presumed consent or opt-out system may increase organ donation rates
Researchers are taking a closer look at the phosphoinositide 3-kinase (PI3-kinase) pathway as studies continue to demonstrate that inhibiting this biological route suppresses tumor growth, reports Genetic Engineering & Biotechnology News (GEN ). The pathway is involved in angiogenesis, cell growth, differentiation, and survival. In addition, it is part of the PI3/AKT/mTOR pathway, which plays
Full Post: Researchers focus on phosphoinositide 3-kinase pathway in cancer research
Introducing presumed consent or opt-out system may increase organ donation rates, suggests a new systematic review published on BMJ.com.
There is currently insufficient supply of donor organs to meet the demand for organ transplantations in the UK. The number of patients registered for a transplant continues to increase. In March 2008, 7,655 patients were on the active transplant list; 506 died in 2007-2008 while waiting for their transplant.
At present the UK has an informed consent legislative system where individuals opt-in if they are willing for their organs to be used after death. However, only a quarter of the UK population are on the NHS donor register.
The review, carried out at the Centre for Reviews and Dissemination (CRD), University of York, combines 26 previous studies and public opinion surveys and represents the most comprehensive review to date examining the impact of having a presumed consent or opt-out system.
The existing evidence, albeit somewhat methodologically limited, suggests that presumed consent legislation is associated with an increase in organ donation rates, though the size of the association varied between studies.
The evidence also suggests that presumed consent alone is unlikely to explain the variation in organ donation rates between different countries. A number of other factors appear to be associated with organ donation rates, though their relative importance is unclear. These factors include deaths from causes most likely to provide organ donors, the transplant co-ordination infrastructure, the wealth and health expenditure of a country, religion, education, and the legislative system.
Underlying public attitudes about organ donation and systems of consent are also likely to be important and the review assessed public and professional attitudes to presumed consent.
Dr Catriona McDaid said: “The survey evidence is incomplete and the variation in attitudes between surveys may reflect differences in methods and the phrasing of questions. Some surveys suggest a lack of public support both in the UK and elsewhere, though the more recent UK surveys do suggest public support for presumed consent.”
A Johns Hopkins study finds that HIV-positive kidney transplant recipients could have the same one-year survival rates for themselves and their donor organs as those without HIV, provided certain risk factors for transplant failure are recognized and tightly managed. “Kidney transplantation is a viable and necessary option for HIV-positive patients with chronic kidney disease, especially
Full Post: Kidney transplant survival can be long-term for people with HIV
When a woman contemplates donating a kidney, she need not worry about any potential health risks it might pose to a future pregnancy, according to a paper being presented at the American Society of Nephrology’s 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania. The research revealed that a woman who has donated a kidney
Full Post: Maternal and fetal outcomes in kidney donors are similar to non-donors
Individuals who are obese face certain risks when donating their kidneys, but their kidney function remains strong one year later, according to a paper being presented at the American Society of Nephrology’s 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania. As the waiting list for kidney transplants grows, transplant centers are working to facilitate
Full Post: Health complications for obese kidney donors
Researchers in the U.S. have discovered a new cancer drug which effectively treats transplant rejections. The researchers from the University of Cincinnati (UC) say the new therapy for transplant patients, targets the antibody-producing plasma cells that can cause organ rejection. According to a study by Dr. Steve Woodle and colleagues, the cancer drug bortezomib which
Full Post: New therapy for transplant rejection
It’s time patient consent forms came back full circle to a tool for patient education, rather than the waiver of liability they have become. The original purpose of the consent forms was for a surgeon or doctor to inform the patient of common or serious risks associated with the procedure to be performed. However, the
Full Post: Informed consent process has lost its educational value